SynthesisEuropean journal of nuclear medicine and molecular imaging2025

Efficacy and safety of rechallenge therapy with [177Lu]Lu-PSMA in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.

Zineddine Belabaci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.